306 related articles for article (PubMed ID: 26080038)
1. Harm Reduction: Front Line Public Health.
Stancliff S; Phillips BW; Maghsoudi N; Joseph H
J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
[TBL] [Abstract][Full Text] [Related]
2. Opioid overdose prevention with intranasal naloxone among people who take methadone.
Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
[TBL] [Abstract][Full Text] [Related]
3. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
[TBL] [Abstract][Full Text] [Related]
4. Harm Reduction Strategies for the Opiod Crisis.
Castillo T
N C Med J; 2018; 79(3):192-194. PubMed ID: 29735629
[TBL] [Abstract][Full Text] [Related]
5. The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy.
Faulkner-Gurstein R
Soc Sci Med; 2017 May; 180():20-27. PubMed ID: 28315595
[TBL] [Abstract][Full Text] [Related]
6. Use of harm reduction strategies by individuals with a history of incarceration: A short report using baseline data collected from the STAMINA clinical trial.
Victor G; Ray B; Watson DP
J Subst Use Addict Treat; 2024 Jul; 162():209376. PubMed ID: 38641053
[TBL] [Abstract][Full Text] [Related]
7. Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice.
Delargy I; Crowley D; Van Hout MC
Harm Reduct J; 2019 Jan; 16(1):5. PubMed ID: 30654803
[TBL] [Abstract][Full Text] [Related]
8. NEXT Harm Reduction: An Online, Mail-Based Naloxone Distribution and Harm-Reduction Program.
Yang C; Favaro J; Meacham MC
Am J Public Health; 2021 Apr; 111(4):667-671. PubMed ID: 33600254
[TBL] [Abstract][Full Text] [Related]
9. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
Bonny-Noach H
Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
[TBL] [Abstract][Full Text] [Related]
10. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
Vearrier L
Dis Mon; 2019 May; 65(5):119-141. PubMed ID: 30600096
[TBL] [Abstract][Full Text] [Related]
11. Between Emergency Department Visits: The Role of Harm Reduction Programs in Mitigating the Harms Associated With Injection Drug Use.
Macias-Konstantopoulos W; Heins A; Sachs CJ; Whiteman PJ; Wingkun NG; Riviello RJ
Ann Emerg Med; 2021 May; 77(5):479-492. PubMed ID: 33579588
[TBL] [Abstract][Full Text] [Related]
12. How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?
Salisbury-Afshar E; Livingston CJ; Bluthenthal RN
AMA J Ethics; 2024 Jul; 26(7):E562-571. PubMed ID: 38958425
[TBL] [Abstract][Full Text] [Related]
13. Harm Reduction in Health Care Settings.
Chan CA; Canver B; McNeil R; Sue KL
Med Clin North Am; 2022 Jan; 106(1):201-217. PubMed ID: 34823731
[TBL] [Abstract][Full Text] [Related]
14. Opioid dependence.
Praveen KT; Law F; O'Shea J; Melichar J
Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
[No Abstract] [Full Text] [Related]
15. [Harm reduction interventions in drug users: current situation and recommendations].
Bosque-Prous M; Brugal MT
Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
[TBL] [Abstract][Full Text] [Related]
16. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
Davidson PJ; Lopez AM; Kral AH
Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
[TBL] [Abstract][Full Text] [Related]
17. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
Strike C; Watson TM
Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
[TBL] [Abstract][Full Text] [Related]
18. Harm reduction drug policies and practice: international developments and domestic initiatives. Overview of a symposium. March 22, 1995.
Drucker E; Hantman JA
Bull N Y Acad Med; 1995; 72(2):335-8. PubMed ID: 10101373
[No Abstract] [Full Text] [Related]
19. Buprenorphine and naloxone interactions in methadone maintenance patients.
Mendelson J; Jones RT; Welm S; Brown J; Batki SL
Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
[TBL] [Abstract][Full Text] [Related]
20. Rationale for cannabis-based interventions in the opioid overdose crisis.
Lucas P
Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
